Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Correlation of CSNK1D expression with clinical features in 110 HCC patients

From: Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3

Parameters

n

CSNK1D expression

P

 

Low

High

 

Sex

   

0.065

Male

93

43

50

 

Female

17

12

5

 

Age

   

0.335

 < 50

63

29

34

 

 ≥ 50

47

26

21

 

AFP(ng/ml)

   

0.175

 < 400

65

36

29

 

 ≥ 400

45

19

26

 

Tumor size

   

0.01

 < 5 cm

41

27

14

 

 ≥ 5 cm

69

28

41

 

Differentiation

   

 < 0.001

Well

35

32

3

 

Moderate & Poor

75

23

52

 

Microvascular Invasion

   

0.021

Yes

24

7

17

 

No

86

48

38

 

TNM stage

   

 < 0.001

I-II

39

30

9

 

III-IV

71

25

46

 

Tumor number

   

0.825

Single

83

41

42

 

Multiple

27

14

13

 

HBV-DNA

   

0.849

 < 1000

55

28

27

 

 ≥ 1000

55

27

28

 

Liver cirrhosis

   

0.563

Yes

63

33

30

 

No

47

22

25

 

Metastasis

   

0.012

Yes

6

0

6

 

No

104

55

49

 

Recurrence

   

0.008

Yes

52

19

33

 

No

58

36

22

 
  1. AFP alpha-fetoprotein, TNM tumor-node-metastasis